People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, ...

Vidofludimus Calcium Substantially Reduced 24-Week Confirmed Disability Worsening in Phase 2 CALLIPER Trial in Overall Progressive Multiple Sclerosis ...

This type of response. The front page of the Friday edition shows about $700,000 in government vehicles, and assuming two men ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

When it comes to compounded Ozempic and other semaglutides, Dr. Goulden adds that they are not identical to their ...

The Centers for Medicare & Medicaid Services (CMS) is developing a pilot program that could change the landscape of obesity ...

The ViruSure test has been developed and evaluated under rigorous conditions and is powered by Oxford Nanopore's advanced molecular sensing platform. It will be used for the detection of viral ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...

As the list of health benefits of semaglutide drugs grows, perhaps it is time to think about assessing their impact on people ...

Scientists are investigating new ways to bring patients back from a vegetative state—and raising uncomfortable questions about the limits of consciousness.

Uppsala University Hospital-led investigators report that gene-edited donor islet cells survived 12 weeks inside a man with ...